Pfizer, Allergan Say FTC Seeking More Info On Inversion Deal
The U.S. Federal Trade Commission is asking Pfizer Inc. and Allergan PLC for more information regarding their proposed merger, which would mark the largest tax inversion deal ever recorded and was...To view the full article, register now.
Already a subscriber? Click here to view full article